全文获取类型
收费全文 | 542446篇 |
免费 | 36259篇 |
国内免费 | 25932篇 |
专业分类
耳鼻咽喉 | 3950篇 |
儿科学 | 11364篇 |
妇产科学 | 7105篇 |
基础医学 | 56608篇 |
口腔科学 | 7640篇 |
临床医学 | 64855篇 |
内科学 | 80435篇 |
皮肤病学 | 4764篇 |
神经病学 | 33940篇 |
特种医学 | 22521篇 |
外国民族医学 | 224篇 |
外科学 | 61210篇 |
综合类 | 71784篇 |
现状与发展 | 86篇 |
一般理论 | 31篇 |
预防医学 | 45192篇 |
眼科学 | 13332篇 |
药学 | 49562篇 |
432篇 | |
中国医学 | 24857篇 |
肿瘤学 | 44745篇 |
出版年
2024年 | 1271篇 |
2023年 | 5446篇 |
2022年 | 14378篇 |
2021年 | 18246篇 |
2020年 | 14409篇 |
2019年 | 11699篇 |
2018年 | 33033篇 |
2017年 | 28260篇 |
2016年 | 29490篇 |
2015年 | 17672篇 |
2014年 | 21695篇 |
2013年 | 19755篇 |
2012年 | 35018篇 |
2011年 | 52067篇 |
2010年 | 39627篇 |
2009年 | 28629篇 |
2008年 | 40328篇 |
2007年 | 42311篇 |
2006年 | 20584篇 |
2005年 | 21297篇 |
2004年 | 15896篇 |
2003年 | 16416篇 |
2002年 | 12399篇 |
2001年 | 8783篇 |
2000年 | 8713篇 |
1999年 | 8547篇 |
1998年 | 5490篇 |
1997年 | 5288篇 |
1996年 | 4040篇 |
1995年 | 3808篇 |
1994年 | 3226篇 |
1993年 | 2081篇 |
1992年 | 2460篇 |
1991年 | 2207篇 |
1990年 | 1912篇 |
1989年 | 1629篇 |
1988年 | 1333篇 |
1987年 | 1220篇 |
1986年 | 976篇 |
1985年 | 704篇 |
1984年 | 387篇 |
1983年 | 291篇 |
1982年 | 166篇 |
1981年 | 169篇 |
1980年 | 153篇 |
1979年 | 156篇 |
1978年 | 81篇 |
1974年 | 61篇 |
1938年 | 62篇 |
1932年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
12.
Weina Cheng Yazhi Wang Jingxian Liu Xiaofei Li Ming Yu Cancan Duan Liu Liu Jianyong Zhang 《Journal of applied toxicology : JAT》2022,42(6):970-980
Cantharidin (CTD) is an effective antitumor agent. However, it exhibits significant hepatotoxicity, the mechanism of which remains unclear. In this study, biochemical and histopathological analyses complemented with ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS)-based targeted metabolomic analysis of bile acids (BAs) were employed to investigate CTD-induced hepatotoxicity in rats. Sixteen male and female Sprague–Dawley rats were randomly divided into two groups: control and CTD (1.0 mg/kg) groups. Serum and liver samples were collected after 28 days of intervention. Biochemical, histopathological, and BA metabolomic analyses were performed for all samples. Further, the key biomarkers of CTD-induced hepatotoxicity were identified via multivariate and metabolic pathway analyses. In addition, metabolite–gene–enzyme network and Kyoto Encyclopedia of Genes and Genomes pathway analyses were used to identify the signaling pathways related to CTD-induced hepatotoxicity. The results revealed significantly increased levels of biochemical indices (alanine aminotransferase, aspartate aminotransferase, and total bile acid). Histopathological analysis revealed that the hepatocytes were damaged. Further, 20 endogenous BAs were quantitated via UHPLC-MS/MS, and multivariate and metabolic pathway analyses of BAs revealed that hyocholic acid, cholic acid, and chenodeoxycholic acid were the key biomarkers of CTD-induced hepatotoxicity. Meanwhile, primary and secondary BA biosynthesis and taurine and hypotaurine metabolism were found to be associated with the mechanism by which CTD induced hepatotoxicity in rats. This study provides useful insights for research on the mechanism of CTD-induced hepatotoxicity. 相似文献
13.
Feng Song Li Ruipiao Wang Zhiying 《Odontology / the Society of the Nippon Dental University》2022,110(3):508-522
Odontology - To investigate the characterization and function of a novel porous osteogenic material (PLLA / DDM) containing polylactic acid and demineralized dentin matrix. The surface morphology... 相似文献
14.
15.
患者男,74岁,主因尿频、尿急、排尿困难10余年,加重1个月,患者因脑梗死后遗症康复治疗于2018年8月1日就诊于天津中医药大学第一附属医院针灸科。查颅脑MR:未见新发梗死灶。患者10余年前发现尿频、尿急、尿不尽、夜尿多等症状,曾诊断“良性前列腺增生”,未经系统诊治。 相似文献
16.
17.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
18.
19.
20.
We report a Chinese family with members affected by epidermolytic ichthyosis (EI), caused by KRT gene mutations. The proband was a 14‐year‐old boy who had simultaneous appearance of nephroblastoma and epidermolytic ichthyosis (EI). Both the patient and his mother exhibited the specific clinical and pathological manifestations of EI. We analysed all exons and flanking sequences of the KRT1 and KRT10 genes using PCR, and found that the proband and his mother had a G>C transition at nucleotide position 1432 in exon 7 of KRT1, resulting in an amino acid substitution of glutamate (GAA) to glutamine (CAA) at codon 478 (E478Q). The KRT10 gene had no mutations. 相似文献